Discussion on Quality Control Management of Immunohistochemistry Pa-thology Technology in Pathological Tissue Section Production
Objective To explore the quality control management of immunohistochemistry pathology technology in the production of pathological tissue sections.Methods Ten staff members of the Department of Pathology of Qufu People's Hospital were selected as study subjects from May 2022 to May 2023,and they were divided into two groups according to the time,May to November 2022 was the no-quality-control group(n=10,routine immunohistochemistry pathology technology),and December 2022 to May 2023 was the quality control group(n=10,and then quality control management based on the no quality control group),and the two groups were compared in terms of excellent rate of preparation,pathological diagnostic results,and poor preparation results.Results The production time and reporting time of the quality control group were significantly shorter than those of the non-quality control group,and the differ-ences were statistically significant(both P<0.05).The scores of production quality,accuracy,adverse events,and pro-duction process of the quality control group were significantly higher than those of the non-quality control group,and the differences were statistically significant(all P<0.05).Conclusion The use of immunohistochemistry pathology technology for quality control management in the production of pathological tissue sections can effectively shorten the production time and reporting time,improve the excellent rate of production and pathological diagnosis results,and re-duce the occurrence of adverse events,which has clinical significance.
Pathological tissueSlice preparationImmunohistochemical pathologyQuality control management
NETL
NSTL
万方数据
